By: Huanjia Zhang
NEW YORK – Thermo Fisher Scientific said on Thursday morning that it is slightly raising the lower end of its full-year 2026 revenue guidance as
Huanjia Zhang is a Science & Health Reporter at various esteemed publications. She focuses on a diverse range of topics including biology, biotechnology, healthcare technology, and the intersection of business and law within the sciences. Huanjia's work has been featured in Truthout, Environmental Health News, 360Dx, Daily Climate, GenomeWeb, and Precision Medicine Quarterly.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
Huanjia Zhang’s coverage revolves around genomics, sequencing technologies, biotechnology, genetic research, and molecular diagnostics. She heavily relies on press releases and data citations for her articles.
Given Huanjia's focus on scientific topics within the healthcare & pharmaceutical industries, she would likely welcome pitches from experts in genomics and molecular diagnostics who can provide unique insights or commentary on emerging trends and breakthroughs in these fields.
As Huanjia does not have a specific geographic focus but rather covers industry-specific news worldwide, sources with international expertise or those involved in global initiatives would be well-suited to reach out to her.
This information evolves through artificial intelligence and human feedback. Improve this profile .